Pharmac to expand access criteria for its three funded COVID-19 antivirals

"The changes in this proposal would provide greater access for people who are vulnerable to severe illness following infection with the currently circulating variants of COVID-19," said Pharmac, adding that the changes are planned to take effect from 1 October 2023. …